RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53
批准号:
6203411
负责人:
William C. Broaddus
金额:
$10.06万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31
关键词:
Adenoviridae apoptosis cell line cell proliferation gene therapy genetic transduction glioma injection /infusion ionizing radiation laboratory rat neoplasm /cancer radiation therapy nonhuman therapy evaluation p53 gene /protein radiation sensitivity single strand conformation polymorphism tissue /cell culture transfection /expression vector tumor suppressor genes
中文摘要
描述:(申请人描述)p53功能紊乱是
英文摘要
DESCRIPTION: (Applicant' Description) Derangements of p53 function are
common in malignant gliomas and may be responsible for the genetic
instability and resistance tot ionizing radiation (IR) that contribute to
the poor prognosis of these tumors. The relationship between p53 and
apoptosis suggests that viral transduction of wild-type (wt) p53 could be
used to impair proliferation and enhance the sensitivity of glioma cells
to IR. Preliminary studies demonstrate that rat malignant glioma cells
when transduced with wt p53 in vitro exhibit decreased clonogenic survival
and increased apoptosis after IR exposure. Implanted in syngeneic rats,
p53 transduced cells form intracerebral tumors similar to control cells
but animals receiving the p53 transduced cells survive significantly
longer than those with control cells. IR appears to further prolong
survival in this group. Preliminary evidence indicates the feasibility of
viral transgene expression in brain and brain tumors by direct
intraparenchymal controlled-rate infusion. It is hypothesized that viral
particle concentrations and interrelated parameters of infusion volume,
rate and pressure will have optima for maximum distribution of
transduction while minimizing tissue disruption.
In four Specific Aims, this project will test the hypothesis that
adenoviral transduction of rodent and human glioma cells with vt p53 can
enhance their radiosensitivity both in vitro and in vivo; (1) the p53
status (wt versus mutant) and susceptibility to adenoviral transduction
will be studied in glioma cell lines to facilitate interpretation of their
responses to IR exposure after p53 transduction. Variability in
transduction efficiency will be determined in a selection of primary human
tumor cell cultures. (2) In vitro studies will determine the ability of
transduced wt p53 to impair proliferation and enhance apoptosis after IR
exposure in rodent and human glial tumor cells. (3) Controlled-rate
positive pressure infusion of adenoviral vector into rat brain and
intracerebral gliomas will determine parameters critical for delivery and
transduction of tumor cells in vivo. Volume of distribution and per cent
transduction will be examined while monitoring behavioral or histological
evidence of toxicity. (4) The effects of p53 transduction on the
radiosensitivity of glioma cells in vivo will be studied with respect to
histology, apoptosis, tumor growth and animal survival. Human cell lines
will be studied after transduction in vivo by positive pressure infusion
prior to irradiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53
-
批准号:6475012
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2001
-
负责人:William C. Broaddus
-
依托单位:
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53
-
批准号:6336438
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2000
-
负责人:William C. Broaddus
-
依托单位:
A PHASE II MULTICENTER TRIAL OF INTRATUMORAL/INTERSTITIAL THERAPY WITH HN-6600
-
批准号:6114902
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1998
-
负责人:William C. Broaddus
-
依托单位:
A PHASE II MULTICENTER TRIAL OF INTRATUMORAL/INTERSTITIAL THERAPY WITH HN-6600
-
批准号:6218495
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:William C. Broaddus
-
依托单位:
RADIOSENSITIZATION OF MALIGNANT GLIOMAS BY VIRAL TRANSDUCTION WITH WILD-TYPE P53
-
批准号:6103328
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1998
-
负责人:William C. Broaddus
-
依托单位:
A PHASE II MULTICENTER TRIAL OF INTRATUMORAL/INTERSTITIAL THERAPY WITH HN-6600
-
批准号:6276137
-
项目类别:
-
资助金额:$3.31万
-
财政年份:1997
-
负责人:William C. Broaddus
-
依托单位:
TRANSFORMATION DEPENDENT GENE EXPRESSION IN GLIOMA CELLS
-
批准号:2036426
-
项目类别:
-
资助金额:$7.51万
-
财政年份:1994
-
负责人:William C. Broaddus
-
依托单位:
TRANSFORMATION DEPENDENT GENE EXPRESSION IN GLIOMA CELLS
-
批准号:2259928
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1994
-
负责人:William C. Broaddus
-
依托单位:
TRANSFORMATION DEPENDENT GENE EXPRESSION IN GLIOMA CELLS
-
批准号:2259929
-
项目类别:
-
资助金额:$7.51万
-
财政年份:1994
-
负责人:William C. Broaddus
-
依托单位:
TRANSFORMATION DEPENDENT GENE EXPRESSION IN GLIOMA CELLS
-
批准号:2771862
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1994
-
负责人:William C. Broaddus
-
依托单位:
TRANSFORMATION DEPENDENT GENE EXPRESSION IN GLIOMA CELLS
-
批准号:2519876
-
项目类别:
-
资助金额:$7.51万
-
财政年份:1994
-
负责人:William C. Broaddus
-
依托单位:
A PHASE II MULTICENTER TRIAL OF INTRATUMORAL/INTERSTITIAL THERAPY WITH HN-6600
-
批准号:6304987
-
项目类别:
-
资助金额:$0.06万
-
财政年份:--
-
负责人:William C. Broaddus
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: